ON
Oncopeptides
ONCO.ST·OMXStockholm SEFounded 2000200 employees
Small CapbiotechPublicHematology
Platform: PDC
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (ONCO.ST)
Loading ONCO.ST stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Mavucapivasertib | ONC-5892 | NDA/BLA | 2 | B7-H3 | PsA | ||
| ONC-2103 | ONC-2103 | Phase 1/2 | 1 | Tau | CTCLAngelman |
SEC Filings & Financial Documents
SEC filings are not available for OMX-listed companies.
Oncopeptides trades on OMX (SE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)